Z69-32253-77529 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-16
Dose 1 — Pfizer-BioNTech
2020-12-28
Registered in v-safe
2020-12-28
Health check-in — day 7, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-30
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-06
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activities

Adult check-in
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache

Adult check-in
2021-01-15
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-23
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-29
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-05
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-12
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-09
Survey response — 3 months, dose 2
MedDRA: Ageusia, Exposure to SARS-CoV-2, Headache, Hyperhidrosis, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair

Free text: Contracted covid. Sorethroat, headache, sweats, no taste and smell, congestion.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-16	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-13	Unsuccessful

Free text

Release 7 — 3 months, dose 2

2021-04-09

Symptoms: Contracted covid. Sorethroat, headache, sweats, no taste and smell, congestion.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	✓	✓	✓
SD	Exposure to SARS-CoV-2	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hyperhidrosis	✓	✓	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Respiratory tract congestion	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release